Pfizer halts Duchenne research

Pfizer is ending two ongoing clinical studies for a Duchenne muscular dystrophy drug after determining that the evidence " did not support a significant treatment effect. ”
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news